One of the world’s leading brand specialists and a part of the WPP network- Landor has carried out a comprehensive brand transformation exercise for injectable products brand- Invengene.
As part of the same, the design agency has carried out a slew of activities including brand positioning, voice and visual identity, all bringing to life Invengene’s ambition within the competitive global injectables market.
With a focus on precision, innovation, and strategic action, Landor has crafted a distinct and recognisable identity that, as per the agency, perfectly reflects the brand’s role in accelerating growth whilst the logo reflects the brand’s dedication to precision and innovation.
One of the key highlights of this collaboration, as per the WPP agency, lies in the introduction of CalMarks, a signature element that embodies precision and reliability in every Invengene product.
“The three Ns in ‘Invengene’ symbolize the brand’s commitment to innovation, quality, and customer satisfaction,” the agency mentioned in a press note, emphasising Invengene as a ‘growth catalyst’ in the pharmaceutical industry.
Expressing their enthusiasm on partnering with Landor, Invengene’s Founders stated, “The injectables industry is complex, which often hampers both effective healthcare and category advancement. There was an opportunity for Invengene to step in to solve this jigsaw. Fuelled by Landor’s strategic vision and creative expertise, our new vision-driven identity showcases precision and reliability in every solution making us poised to lead the way in revolutionizing the injectables market. Our partnership with Landor exemplifies a synergistic collaboration driving innovation in the pharmaceutical landscape.”
To this, Ronita Mukerjee, Executive Director- Client Services, Landor India, added, “Through a purpose-driven brand positioning and a unique brand identity; we were able to help Invengene stand out and stand for something in a very cluttered category. We are proud to have played a role in elevating Invengene as a dynamic growth catalyst in the injectables space.”
